Holocene Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Hold |
8,470
| – | – | ﹤0.01% | 700 |
|
|
2025
Q1 | $599K | Buy |
+8,470
| New | +$599K | ﹤0.01% | 656 |
|
|
2024
Q4 | – | Sell |
-563,476
| Closed | -$39.6M | – | 755 |
|
|
2024
Q3 | $39.6M | Sell |
563,476
-149,628
| -21% | -$10.5M | 0.16% | 172 |
|
|
2024
Q2 | $58.7M | Buy |
713,104
+517,108
| +264% | +$42.6M | 0.25% | 125 |
|
|
2024
Q1 | $17.1M | Buy |
+195,996
| New | +$17.1M | 0.06% | 222 |
|
|
2018
Q2 | – | Sell |
-3,139
| Closed | -$254K | – | 570 |
|
|
2018
Q1 | $254K | Sell |
3,139
-8,074
| -72% | -$653K | 0.01% | 429 |
|
|
2017
Q4 | $1M | Buy |
+11,213
| New | +$1M | 0.03% | 125 |
|